HbA1c Rapid Quantitative Test-It is intended to quantify the percentage of HbA1c in human whole blood on Biotime FIA Analyzer by fluorescent immunoassay.The test is used as an aid in management and monitoring of the long-term glycemic status in patients with diabetes mellitus.,β-hCG Rapid Quantitative Test - India CDSCO Medical Device Registration

HbA1c Rapid Quantitative Test-It is intended to quantify the percentage of HbA1c in human whole blood on Biotime FIA Analyzer by fluorescent immunoassay.The test is used as an aid in management and monitoring of the long-term glycemic status in patients with diabetes mellitus.,β-hCG Rapid Quantitative Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000035_457ecd90cd552e89fc273215d9ff2a00_44fd7d0d4aaf09ca6c9cf9bf7ceefe88. This device is marketed under the brand name Immunoglobulin E. The license holder is DIYA SCIENTIFIC, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.